JRUD:LSE:LSE-JPMorgan ETFs (Ireland) ICAV - US Research Enhanced Index Equity UCITS ETF - USD (inc) (USD)

ETF | Others |

Last Closing

USD 52.13

Change

0.00 (0.00)%

Market Cap

USD 0.58B

Volume

118.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-07 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XNID:LSE Xtrackers Nifty 50 Swap UCITS ..

-0.50 (-0.18%)

USD 292,109.69B
XMTD:LSE Xtrackers MSCI Taiwan UCITS ET..

-1.73 (-2.45%)

USD 292,109.19B
0R1O:LSE Amazon.com Inc.

-8.75 (-4.45%)

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

-7.65 (-6.04%)

USD 618.20B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

-0.06 (-0.40%)

USD 586.49B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

-0.01 (-0.05%)

USD 586.49B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
XDJP:LSE Xtrackers Nikkei 225 UCITS ETF..

-32.00 (-1.53%)

USD 341.28B
0QZK:LSE Coca-Cola Co.

+0.90 (+1.41%)

USD 266.08B
0QZO:LSE 0QZO

-0.95 (-0.97%)

USD 258.54B

ETFs Containing JRUD:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 16.75% 89% A- 83% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 16.75% 89% A- 83% B
Trailing 12 Months  
Capital Gain 28.06% 87% B+ 82% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 28.06% 87% B+ 82% B
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 11.07% 73% C 74% C
Dividend Return 11.07% 73% C 73% C
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 11.91% 56% F 73% C
Risk Adjusted Return 92.93% 94% A 96% N/A
Market Capitalization 0.58B 71% C- 54% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike